Homšek A, Jovanović M, Miljković B, Vučićević K. Assessment of pembrolizumab exposure in different patient subpopulations using pharmacometric simulation. arhfarm [Internet]. 2022 Oct. 12 [cited 2026 Jul. 12];72(Suppl. 4):S227-S228. Available from: https://asistent.ceon.rs/index.php/arhfarm/article/view/38447